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ABSTRACT The nucleotide sequence of the mRNA encod-
ing the F protein of respiratory syncytial (RS) virus (strain A2)
was determined from cDNA clones that contain the complete
mRNA sequence. The mRNA is 1899 nudeotides long exclu-
sive of polyadenylylate. The single major open reading frame
encodes a protein of 574 amino acids, with a calculated molec-
ular weight of 63,453. Major structural features predicted
from the amino acid sequence include an NH2-terminal signal
sequence (residues 1-22), hydrophobic transmembrane an-
chor sequence (residues 525-550), five potential acceptor sites
for asparagine-linked carbohydrate, and a potential site (resi-
dues 131-136) for the proteolytic cleavage that generates the
disulfide-linked F1 and F2 subunits, which, by analogy to other
paramyxoviruses, constitute the biologically active form of the
F protein. The sequence also contains an internal hydrophobic
domain (residues 137-154) that, as a consequence of the acti-
vating proteolytic cleavage described above, would become the
NH2 terminus of the larger, F1 subunit. The amino acid se-
quence of the hydrophobic terminus of the F1 subunit is known
to be highly conserved among several paramyxoviruses but is
markedly dissimilar for RS virus. The F2 subunit is relatively
hydrophilic and contains four of the five potential carbohy-
drate acceptor sites. The subunit order is NH2-F2-F1-COOH.
The nucleotide sequences at the 5' and 3' mRNA termini are
conserved among the eight RS viral mRNAs sequenced to date.
The conserved sequences are: 5' G-G-G-G-C-A-A-A-U ... A-
G-U-A4A-(N)o.2-A-U-poly(A). These are candidates to be sig-
nals for viral transcription. The nucleotide and amino acid se-
quences described further define the relationship between RS
virus and other paramyxoviruses.
Human respiratory syncytial virus (RS virus) is an important
agent of serious respiratory tract disease in infants and chil-
dren (1). A safe and effective vaccine for RS virus is unavail-
able, and the factors involved in the unusual pathogenesis of
RS virus and the development of host immunity are poorly
understood (1).
RS virus has general similarities with the paramyxoviruses
and is classified provisionally within that family (2). As with
other paramyxoviruses (3), the envelope of RS virus con-
tains two surface glycoproteins. The Mr 84,000 glycoprotein
(G) mediates attachment to target cells (4, 5), and the sec-
ond, Mr 68,000 glycoprotein is the viral fusion (F) glycopro-
tein (4). Work with Sendai virus and other prototypic para-
myxoviruses demonstrated that the F protein directs fusion
of viral and cellular membranes resulting in viral penetration
and can direct fusion of infected cells with adjoining cells
resulting in the formation of syncytia (3, 6). Syncytia forma-
tion is both a prominent cytopathic effect and an additional
mechanism of viral spread (6). Neutralization of fusion activ-
ity is important in host immunity (6). The active paramyxo-
virus F protein consists of two disulfide-linked units, F1 and
F2, which are generated from an inactive precursor, F0, by a
specific internal cleavage by cellular proteases (7-11). The
availability of an appropriate cellular protease and the sus-
ceptibility of the F0 protein to the requisite cleavage are im-
portant parameters in paramyxovirus pathogenesis (9, 10).
However, the sequence of the F protein was not known for
either the prototypic paramyxoviruses or for RS virus.
By the use ofcDNA cloning, we recently showed that the
RS viral genome, a single negative strand of RNA (12, 13),
encodes 10 unique mRNAs (12-16). The proteins encoded by
the 10 viral mRNAs were identified by hybrid-selection and
in vitro translation (16). One of the in vitro translation prod-
ucts, a Mr 59,000 species, was identified by peptide mapping
as the unglycosylated and uncleaved form of the F protein
(refs. 12, 17; unpublished data). These data identified mRNA
5, Mr 0.74 x 106 (13, 15), as the F mRNA.
In the work described here, we constructed complete
cDNA clones of the F mRNA and deduced, by DNA se-
quencing, the sequences of the mRNA and the encoded F
protein.
MATERIALS AND METHODS
cDNA Clones. cDNAs were synthesized with intracellular
viral mRNA as template, inserted into the Pst I site of
pBR322 by homopolymer tailing, and cloned in Escherichia
coli HB101. cDNAs 5-1 and 5-2 were isolated from a library
constructed in previous work (15). A second library was con-
structed essentially as described by Land et al. (18), except
that size selection on a 1.5% agarose gel followed the final
poly(dC) tailing step.
DNA Sequence Analysis. DNA sequences were determined
by the chemical method of Maxam and Gilbert (19).
Primer Extension. Recombinant plasmid 5-26 (100 ,ug) was
digested with Hpa II and Dde I, and the 228-base-pair (bp)
fragment spanning the cDNA terminus (bp 3550 in pBR322
to bp 149 in the 5-26 sequence, inclusive) was isolated, 5'
end-labeled (19), digested with Pst I, and electrophoresed on
a 6% sequencing gel. The 89-nucleotide (nt), antimessage
sense strand (nt 61-149 in cDNA 5-26), which was resolved
from its complement because it was 7 nt longer, was recov-
ered and used as a primer. Each primer extension reaction
(20 ,l) contained 0.5 pmol of primer (5 x 105 dpm), 5 M.g of
intracellular viral mRNA (16), 100 mM Tris HCl (pH 8.3),
140 mM KCl, 8 mM magnesium acetate, 30 mM 2-mercapto-
ethanol, 80 ,ug of actinomycin D per ml, 200 ,uM dATP, and
100 ,uM (each) dCTP, dTTP, and dGTP. Reactions were
preincubated at 42°C for 30 min, 20 units of reverse tran-
scriptase (Life Sciences, St. Petersburg, FL) was added, and
Abbreviations: RS virus, respiratory syncytial virus; F protein, fu-
sion protein; F mRNA, fusion protein mRNA; nt, nucleotide(s); bp,
base pair(s).
*Present address: Laboratory of Infectious Diseases, National Insti-
tutes of Health, Bethesda, MD 20205.
tPresent address: Department of Pathology, Case Western Univer-
sity School of Medicine, Cleveland, OH 44106.
7683
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
7684 Biochemistry: Collins et al.
incubation was continued for 1 hr. Chain-termination reac-
tions contained, in addition, 33 AM ddGTP, 50 AM ddATP,
33 ,M ddTTP, or 50 ,.M ddCTP. Nucleic acids were precip-
itated with ethanol and analyzed on a 6% sequencing gel.
Chemical Sequencing of the Extended Primer. Four pico-
moles of 5' end-labeled primer (4 x 106 dpm) were extended
as described above, precipitated once with ethanol, resus-
pended in 100 Al of water, dissociated from the RNA tem-
plate by boiling for 2 min, cooled, immediately used to pre-
pare a 150-il reaction containing 25 mM potassium cacodyl-
ate (pH 7.2), 1 mM CoCl2, 0.2 mM dithioerythritol, 0.5 mM
dTTP, and 75 units of terminal transferase (P-L Biochemi-
cals), and incubated for 4 min at 15'C. Nucleic acids were
purified with phenol, precipitated with ethanol, and electro-
phoresed on a 6% sequencing gel. The extended, tailed prim-
er was recovered and sequenced by the chemical method.
RESULTS AND DISCUSSION
cDNA Sequencing. The strategy for sequencing cDNAs of
the F mRNA is shown in Fig. 1. Every position in the com-
plete nucleotide sequence was determined from a minimum
of two independent cDNAs. Much of the sequence was ob-
tained from two nearly complete cDNAs, 5-1 and 5-2; se-
quencing was completed on seven approximately full-length
cDNAs represented by cDNA 5-26 (Fig. 1). The cDNA end
that is 5' relative to the mRNA was identified by primer ex-
tension experiments described below. The 3' end was identi-
fied by the detection of terminal poly(dA) (8-20 residues) in
five of the seven approximately full-length cDNAs.
Mapping and Sequencing of the 5' mRNA End. To examine
the sequence of the 5' mRNA end, an 89-nt DNA primer was
hybridized to mRNA and extended to the 5' terminus with
reverse transcriptase (Fig. 2a). If the 5-26 cDNA insert ex-
clusive of the poly(dG) tract contained the complete 5'
mRNA sequence, the primer would have been increased in
length by 56 nt. Instead, the major extension product was
increased by 60 nt. A second, minor extension product that
was longer than the major product by 1 nt was also obtained.
In previous work, analogous longer extension products were
obtained and appeared to be artifactual, possibly generated
by inefficient copying of the mRNA cap (20). We therefore
considered the major extension product to represent the au-
thentic mRNA end.
Primer extension under conditions of partial chain termi-
nation (Fig. 2a) identified the additional 4 nt at the mRNA
terminus as, written in mRNA sense, 5' N-G-G-G. To pre-
cisely identify the terminal nucleotide, an extended primer
(5' end-labeled) was prepared, a poly(dT) tail was added to
- - -* , . + ,, 5-1
the 3' end, and the product was sequenced by the chemical
method (Fig. 2b). The deduced sequence of the mRNA end
was 5' (G)-G-G-G-G. The G in parentheses represents the
additional nucleotide contributed by the minor extension
product described above and might represent a cap struc-
ture. We concluded that the italicized sequence represents
the authentic, exact 5' mRNA end. In the cloned cDNA,
these sequences are indistinguishable from the adjoining
poly(dG) tail added during cloning. Thus, five of the cDNAs
analyzed in this work contain the complete mRNA se-
quence.
Nucleotide Sequence of the F mRNA. The complete se-




















































0 400 800 1200
BASE PAIRS
1600 2000
FIG. 1. Strategy for DNA sequencing. cDNAs 5-1, 5-2, and 5-26
are drawn to scale with the poly(dG)-poly(dC) tails omitted. The
orientation from left to right is 5' to 3' relative to the mRNA. The
arrows indicate the directions and extents of sequence determina-
tion in the message-sense strand (arrows above the line) and an-
timessage strand (below the line). Double slash marks in certain ar-
rows indicate that sequencing spanned the F cDNA boundary. Sev-
en additional, confirmatory fragments analyzed in 5-2 are not
shown. The DNA fragment that was used in primer extension ex-
periments is shown. Although not shown, a second complete cDNA,
5-7, was sequenced to an extent similar to 5-26, and the sequences at
the termini of 5-26 and 5-7 were confirmed in five additional cDNAs.
FIG. 2. Mapping the 5' end of the F mRNA. (A) An 89-nt, 5' end-
labeled primer was hybridized to mRNA and extended to the 5'
mRNA end: 104 dpm (lanes 1 and 4) and 2 x 10i dpm (lane 5) of the
reaction products were analyzed on a 6% sequencing gel in parallel
with G + A (lane 2) and C + T (lane 3) chemical sequencing ladders
prepared from an unrelated DNA. The positions of the unreacted
primer (closed circle), major extension product (closed arrow), and
minor extension product (open arrow) are marked. Lanes G, A, T,
and C represent partial chain-termination reactions containing the
appropriate ddNTP. The deduced nucleotide sequence (antimessage
sense) is shown. (B) The 5'-labeled primer was elongated on mRNA,
extended further at the 3' end with poly(dT), sequenced by the
chemical method, analyzed on a 6% sequencing gel, and visualized
with an intensifying screen. The lane headings denote the reaction
specificities: lane G, G; lane A, G + A; lane T, C + T; and lane C,
C. The deduced nucleotide sequence (antimessage sense) is shown.
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(Fig. 3). The mRNA contains a single long open reading
frame, which begins with the first ATG (nt 14-16) and ac-
counts for 91% of the sequence. The other reading frames,
including the three in the antimessage strand, are blocked
extensively throughout the sequence (not shown). The pro-
posed major open reading frame encodes a polypeptide of
574 amino acids with a calculated Mr of 63,453. This is in
good agreement (8% larger) with the Mr of 59,000 estimated
by gel electrophoresis for unprocessed F protein synthesized
in vitro (12, 14, 16).
The next longest open reading frame initiates with the trip-
let ATG (nt 39-41), ends with the triplet TGA (nt 156-158),
and would encode a polypeptide of 39 amino acids (Fig. 3).
This open reading frame is noteworthy because of its prox-
imity to the 5' mRNA end: the initiator codon is the second
ATG in the sequence. Translation of secondary open reading
frames has been reported in cases in which the initiating co-
dons are 5' proximal (21, 22). However, we have no evi-
dence that this second open reading frame in the F mRNA is
utilized.
Preliminary comparison of the sequence of the F mRNA
with those of the 1A, 1B, and 1C mRNAs (unpublished re-
sults) and the mRNAs that encode the major nucleocapsid
protein (ref. 23; unpublished results), matrix protein (24), 24-
kilodalton protein, and G protein (unpublished data) identi-
fied consensus sequences at both mRNA termini (Fig. 4).
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These conserved sequences were overlooked in published
work (23, 24). The mRNAs of Sendai virus (Fig. 4) and the
rhabdovirus vesicular stomatitis virus (26) contain similar
consensus termini (Fig. 4) that are transcribed from the con-
served 22- or 23-nt sequences that extend across each inter-
genic region in the viral genomes (20, 22, 25, 26). For Sendai
virus and vesicular stomatitis virus, these sequences are
thought to have functional roles in viral transcription and
have been proposed to have evolutionary significance (20,
22, 25, 26). The identification of similar sequences in RS vi-
ral mRNAs suggests that some fundamental similarities exist
in the structure, function, and possibly origin of these viral
RNAs. As shown in Fig. 4, the 5' conserved RS viral se-
quence, 5' G-G-G-G-C-A-A-A-U ..., is generally similar in
length and sequence to that of Sendai virus. The 3' termini of
several RS viral mRNAs resembled the Sendai viral 3' con-
sensus sequence. However, the 3' sequence that was con-
served among all eight RS viral mRNAs, 5'... A-G-U-AA-
(N)O..2-A-U-poly(A), differed in length, pEdition, and se-
quence from the Sendai viral consensus sequence. It will be
of interest to extend this preliminary comparison to the RS
viral intergenic sequences as well as to the sequences of otb-
er paramyxoviruses as they become available.
Structure of the F Protein. The amino acid sequence pre-
sented in Fig. 3 provided the basis for predicting major struc-
G GGG CAA ATA ACA ATG GAG TTG CTA ATC CTC AAA GCA AAT GCA ATT ACC ACA ATC CTC ACT GCA GTC ACA TTT TGT TTT GCT TCT 8 5
Met Gl Leeu Eeu Ile Leu Lys Ala Asn Ala Ile Thr Thr Ile Leu Thr Ala Val Thr Phe Cys Phe Ala Ser 24
GGT CAA AAC ATC ACT GAA GAA TTT TAT CAA TCA ACA TGC AGT GCA GTT AGC AAA GGC TAT CTT AGT GCT CTG AGA ACT GGT TGG TAT ACC AGT GTT ATA ACT ATA 19 0
Gly Gln Asn Ile Thr Glu Glu Phe Tyr Gln Ser Thr Cys Ser Ala Val Ser Lys Gly Tyr Leu Ser Ala Leu Arg Thr Gly Trp Tyr Thr Ser Val Ile Thr Ile 59
A (D
GAA TTA AGT AAT ATC AAG GAA AAT AAG TGT AAT GGA ACA GAT GCT AAG GTA AAA TTG ATA AAA CAA GAA TTA GAT AAA TAT AAA AAT GCT GTA ACA GAA TTG CAG 2 9 5
Glu Leu Ser Asn Ile Lys Glu Asn Lys Cys Asn Gly Thr Asp Ala Lys Val Lys Leu Ile Lys Gln Glu Leu Asp Lys Tyr Lys Asn Ala Val Thr Glu Leu Gln 94
A
TTG CTC ATG CAA AGC ACA CCA CCA ACA AAC AAT CGA GCC AGA AGA GAA CTA CCA AGG TTT ATG AAT TAT ACA CTC AAC AAT GCC AAA AAA ACC AAT GTA ACA TTA 4 00
Leu Leu Met Gln Ser Thr Pro Pro Thr Asn Asn Arg Ala Arg Arg Glu Leu Pro Arg Phe Met Asn Tyr Thr Leu Asn Asn Ala Lys Lys Thr Asn Val Thr Leu 1 29
A A
AGC AAG AAA AGG AAA AGA AGA TTT CTT GGT TTT TTG TTA GGT GTT GGA TCT GCA ATC GCC AGT GGC GTT GCT GTA TCT AAG GTC CTG CAC CTA GAA GGG GAA GTG 5 05
Ser Lys Lys Arg Lys Arg Arg Phe Leu Gly Phe Leu Leu Gly Val Gly Ser Ala Ile Ala Ser Gly Val Ala ValSer Lys Val Leu His Leu Glu Gly Glu Val 164A
AAC AAG ATC AAA AGT GCT CTA CTA TCC ACA AAC AAG GCT GTA GTC AGC TTA TCA AAT GGA GTT AGT GTC TTA ACC AGC AAA GTG TTA GAC CTC AAA AAC TAT ATA 610
Asn Lys Ile Lys Ser Ala Leu Leu Ser Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gly Val Ser Val Leu Thr Ser Lys Val Leu Asp Leu Lys Asn Tyr Ile 199
GAT AAA CAA TTG TTA CCT ATT GTG AAC AAG CAA AGC TGC AGC ATA ICA AAT ATA GAA ACT GTG ATA GAG TTC CAA CAA AAG AAC AAC AGA CTA CTA GAG ATT ACC 715
Asp Lys Gln Leu Leu Pro Ile Val Asn Lys Gln Ser Cys Ser Ile Ser Asn Ile Glu Thr Val Ile Glu Phe Gln Gln Lys Asn Asn Arg Leu Leu Glu Ile Thr 234
0
AGG GAA TTT AGT GTT AAT GCA GGT GTA ACT A4A CCT GTA AGC ACT TAC ATG TTA ACT AAT AGT GAA TTA TTG TCA TTA ATC AAT GAT ATG CCT ATA ACA AAT GAT 820
Arg Glu Phe Ser Val Asn Ala Gly Val Thr Thr Pro Val Ser Thr Tyr Met Leu Thr Asn Ser Glu Leu Leu Ser Leu Ile Asn Asp Met Pro Ile Thr Asn Asp 269
CAG AAA AAG TTA ATG TCC AAC AAT GTT CAA ATA GTT AGA CAG CAA AGT TAC TCT ATC ATG TCC ATA ATA AAA GAG GAA GTC TTA GCA TAT GTA GTA CAA TTA CCA 9 25
Gln Lys Lys Leu Met Ser Asn Asn Val Gln Ile Val Arg Gln Gln Ser Tyr Ser Ile Met Ser Ile Ile Lys Glu Glu Val Leu Ala Tyr Val Val Gln Leu Pro 304
CTA TAT GGT GTT ATA GAT ACA CCC TGT TGG AAA CTA CAC ACA TCC CCT CTA TGT ACA ACC AAC ACA AAA GAA GGG TCC AAC ATC TGT TTA ACA AGA ACT GAC AGA 1030
Leu Tyr Gly Val Ile Asp Thr Pro Cys Trp Lys Leu His Thr Ser Pro Leu Cys Thr Thr Asn Thr Lys Glu Gly Ser Asn Ile Cys Leu Thr Arg Thr Asp Arg 3 39
O E) 0
GGA TGG TAC TGT GAC AAT GCA GGA TCA GTA TCT TTC TTC CCA CAA GCT GAA ACA TGT AAA GTT CAA TCA AAT CGA GTA TTT TGT GAC ACA ATG AAC AGT TTA ACA 1135
Gly Trp Tyr Cys Asp Asn Ala Gly Ser Val Ser Phe Phe Pro Gln Ala Glu Thr Cys Lys Val Gln Ser Asn Arg Val Phe Cys Asp Thr Met Asn Ser Leu Thr 3 74
TTA CCA AGT GAA ATA AAT CTC TGC AAT GTT GAC ATA TTC AAC CCC AAA TAT GAT TGT AAA ATT ATG ACT TCA AAA ACA GAT GTA AGC AGC TCC GTT ATC ACA TCT 1240
Leu Pro Ser Glu Ile Asn Leu Cys Asn Val Asp Ile Phe Asn Pro Lys Tyr Asp Cys Lys Ile Met Thr Ser Lys Thr Asp Val Ser Ser Ser Val Ile Thr Ser 4 09
a a)
CTA GGA GCC ATT GTG TCA TGC TAT GGC AAA ACT AAA TGT ACA GCA TCC AAT AAA AAT CGT GGA ATC ATA AAG ACA TTT TCT AAC GGG TGC GAT TAT GTA TCA AAT 13 4 5
Leu Gly Ala Ile Val Ser Cys Tyr Gly Lys Thr Lys Cys Thr Ala Ser Asn Lys Asn Arg Gly Ile Ile Lys Thr Phe Ser Asn Gly Cys Asp Tyr Val Ser Asn 4 44
a a 5
c
AAA GGG ATG GAC ACT GTG TCT GTA GGT AAC ACA TTA TAT TAT GTA AAT AAG CAA GAA GGT AAA AGT CTC TAT GTA AAA GGT GAA CCA ATA ATA AAT TTC TAT GAC 14 5 0
Lys Gly Met Asp Thr Val Ser Val Gly Asn Thr Leu Tyr Tyr Val Asn Lys Gln Glu Gly Lys Ser Leu Tyr Val Lys Gly Glu Pro Ile Ile Asn Phe Tyr Asp 4 79
CCA TTA GTA TTC CCC TCT GAT GAA TTT GAT GCA TCA ATA TCT CAA GTC AAC GAG AAG ATT AAC CAG AGC CTA GCA TTT ATT CGT AAA TCC GAT GAA TTA TTA CAT 15 5 5
Pro Leu Val Phe Pro Ser Asp Glu Phe Asp Ala Ser Ile Ser Gln Val Asn Glu Lys Ile Asn Gln Ser Leu Ala Phe Ile Arg Lys Ser Asp Glu Leu Leu His 514A
AAT GTA AAT GCT GGT AAA TCC ACC ACA AAT ATC ATG ATA ACT ACT ATA ATT ATA GTG ATT ATA GTA ATA TTG TTA TCA TTA ATT GCT GTT GGA CTG CTC TTA TAC 1660
Asn Val Asn Ala Gly Lys Ser Thr Thr Asn Ile Met Ile Thr Thr Ile Ile Ile Val Ile Ile Val Ile Leu Leu Ser Leu Ile Ala Val Gly Leu Leu Leu Tyr 549
TGT AAG GCC AGA AGC ACA CCA GTC ACA CTA AGC AAA GAT CAA CTG AGT GGT ATA AAT AAT ATT GCA TTT AGT AAC TAA ATA AAA ATA GCA CCT AAT CAT GTT CTT 1765
Cys Lys Ala Arg Ser Thr Pro Val Thr Leu Ser Lys Asp Gln Leu Ser Gly Ile Asn Asn Ile Ala Phe Ser Asn * 574
ACA ATG GTT TAC TAT CTG CTC ATA GAC AAC CCA TCT GTC ATT GGA TTT TCT TAA AAT CTG AAC TTC ATC GAA ACT CTC ATC TAT AAA CCA TCT CAC TTA CAC TAT 1870
TTA AGT AGA TTC CTA GTT TAT AGT TAT AT 18 9 9
FIG. 3. Nucleotide sequence of the F mRNA and the predicted protein sequence. The NH2-terminal and COOH-terminal hydrophobic
domains are underlined. The hydrophobic domain at the predicted NH2 terminus of the F1 subunit is marked with double underlining. The
arrow marks the predicted site of the proteolytic cleavage that activates fusion activity. The positions of cysteine residues (circles) and potential
asparaginyl acceptor sites for carbohydrate (closed triangles) are marked below the amino acid sequence. Nucleotide variability was detected at
seven positions (marked with ticks above the nucleotide sequence): position 303, shown as T, was C in one of three cDNAs (changing Met to
Thr); position 317, C, was Tin two of four cDNAs (Pro to Ser); position 342, A, was C in one of four cDNAs (Glu to Ala); position 573, T, was C
in one of four cDNAs (Val to Ala); position 915, T, was C in one of four cDNAs (Val to Ala); position 1148, A, was G in two of four cDNAs (Ile
to Val); position 1352, A, was G in two of four cDNAs (Met to Val).





. . . AUUAGUUAAUAU-polyA
... CGAUAGUUAUUU-polyA
. . . CUUUGAGUUAAU-polyA
. . CAGUAGUUACUU-polyA
... AAAUAAGUUAAU-pOlyA
FIG. 4. Conserved sequences at the termini of RS viral mRNAs.
The RS viral sequences were compiled from our unpublished work
(a) and the work of Elango and Venkatesan (23) (b) and Satake and
Venkatesan (24) (c). As shown, the N mRNA sequence that we ob-
tained (unpublished work) is different at the 3' end than the pub-
lished sequence (23). This discrepancy will be discussed elsewhere.
For comparison, Sendai viral consensus sequences were compiled
from published work (20, 22, 25). Symbols in the nucleotide se-
quences: N, unidentified nucleotide for the RS viral mRNAs and
variable nucleotide for the Sendai viral mRNAs; (nd), mRNA termi-
nus has not been sequenced or mapped exactly.
tural features of the Fo protein. These are discussed below in
the context of information available from other sources.
Glycosylation of the Fo protein was inhibited completely
in the presence of tunicamycin (12, 17), indicating that car-
bohydrate side chains are attached exclusively through N-
linkage to asparagine residues. The glycosylated and nongly-
cosylated forms of Fo protein differed in apparent size by
11,000 daltons. Assuming a contribution of 2100 daltons per
carbohydrate chain (27), five chains are predicted. The ami-
no acid sequence contains five potential acceptor sites for N-
linked carbohydrate (Asn-X-Ser/Thr), suggesting that all po-
tential sites are utilized. The placement of four of the accep-
tor sites in the F2 subunit (Figs. 3 and 5) is consistent with
the electrophoretic mobilities of the glycosylated and non-
glycosylated, reduced and nonreduced forms of the FO and F
protein (12, 17).
The biosynthesis and membrane orientation of glycopro-
teins is mediated by characteristic hydrophobic "signal" se-
quences in the polypeptide chain (28, 29). To search for pos-
sible hydrophobic signals in the sequence of Fo protein, a
plot of local hydrophobicity versus sequence position was
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FIG. 5. Plot of hydrophilic (areas above the line) and hydropho-
bic (below the line) regions in the unprocessed F protein. A window
of 14 amino acids was used to calculate local hydrophobicity of each
position based on published hydrophobicity values (30) (local hydro-
phobicity equals the average of the values for each group of 14 ami-
no acids). The deduced positions of (i) the NH2-terminal signal pep-
tide, (ii) the proposed NH2 terminus of the F1 subunit, and (iii) the
transmembrane anchor are shown. The proposed site for the activat-
ing proteolytic cleavage is marked with an arrow. Potential acceptor
sites for N-linked carbohydrate are marked with open triangles.
prepared (Fig. 5). The NH2 terminus of the F0 protein (amino
acids 1-22) is strongly hydrophobic and is similar in length
and amino acid content to known NH2-terminal signal pep-
tides (28, 29, 31). By analogy we presume that this sequence
is a signal peptide that initiates translocation of nascent F0
protein across the membrane and into the lumen of the rough
endoplasmic reticulum. Most known NH2-terminal signal
peptides are cleaved by a signal peptidase during or after
translocation (28, 29, 31). In the case of the RS virus F pro-
tein, unglycosylated F0 protein synthesized in tunicamycin-
treated cells was 2000 daltons smaller than its unprocessed
counterpart synthesized in vitro in the absence of mem-
branes (12). We attribute this difference to a cleaved signal
sequence (29). Thus, the amino acid sequence shown in Fig.
3 probably represents pre-F0 protein; F0 protein would be
generated by cleavage of the signal peptide. Based on the
size estimate for the signal peptide and the observed prefer-
ence of the signal peptidase for cleavage following glycine,
serine, alanine, and cysteine (31), cleavage might occur fol-
lowing amino acids 17, 21, or 23.
The most strongly hydrophobic region of the F0 protein is
near the COOH terminus (amino acids 525-55b, Figs. 3 and
5). The length and amino acid content of this sequence is
characteristic of known "stop-transfer" signals (28, 29).
These have been shown to terminate passage of the nascent
polypeptide -through the membrane, with the stop-transfer
signal remaining embedded in the membrane and the poly-
peptide positioned in a transmembrane orientation (28, 29).
For the Fo protein, the region predicted to be external in-
cludes the NH2 terminus, 91% of the amino acid sequence,
all five potential carbohydrate acceptor sites, and 15 of 16
cysteine residues (Fig. 3). Tht COOH-terminal region,
which consists of 24 amino acids and is moderately hydro-
philic and moderately basic, would remain in the cytoplasm.
This is consistent with the membrane orientation of the Sen-
dai virus F0 protein (32). The single cysteine residue at the
cytoplasmic membrane face is a potential acceptor site for
palmitate (33).
As has been demonstrated with Sendai virus and other
prototypic paramyxoviruses, the NH2 terminus of the para-
myxovirus F1 subunit is generated by the cleavage that acti-
vates the F protein. Amino acid sequencing determined that
this newly exposed terminus is strongly hydrophobic (34,
35). For RS virus, the NH2 terminus of the F1 subunit has
not been identified directly. On the basis of the predicted
amino acid sequence (Fig. 3), the best candidate to be the
site of the activating cleavage is the sequence Lys-Lys-Arg-
Lys-Arg-Arg (amino acids 131-136). This sequence would
have a marked sensitivity to trypsin-like proteases and
cleavage would generate F1 and F2 subunits with molecular
weights in agreement with estimates made by gel electropho-
resis (12, 36, 37). The predicted subunit order, NH2-F2-F1-
COOH, is the same as for Sendai virus (11, 32). More impor-
tant, the NH2 terminus that would be created by cleavage at
this site is strongly hydrophobic (Figs. 3 and 5).
For other paramyxoviruses, several lines of evidence sug-
gested that the hydrophobic NH2 terminus of the F1 poly-
peptide has an important role in fusion: (i) the cleavage that
activates fusion activity exposes a new hydrophobic domain
in the native protein (38), (ii) the amino acid sequence of the
F1 subunit terminus is highly conserved among several para-
myxoviruses (35), and (iii) synthetic peptides that mimic this
sequence inhibit fusion (35). It therefore was of interest to
compare the predicted NH2-terminal sequence of the F1
polypeptide of RS virus with that of Sendai virus (Fig. 6).
Surprisingly, the sequences are dissimilar: 4 of 20 positions
are in agreement, compared to 14 of 20 amino acids in com-
mon among Sendai virus, Newcastle disease virus, and simi-
an virus 5, three paramnyxoviruses that have different avian
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RS VIRUS NH2-Phe-Leu-gj-Phe-Leu-Leu-G1 -Val-Gly-Ser-Ala-Ile-Aia-Ser-Gly-Val-Ala-Val-Ser-Lys ...
SENDAI NH2-Phe-Phe-Gly-Ala-Val-Ile-GlZ-Thr-Ile-Ala-Leu-G l-Va1-A1A-Thr-Ala-Ala-Gln-Ile-Thr
FIG. 6. Comparison of the amino acid sequence at the proposed NH2 termini of the F1 polypeptide ofRS virus with that of Sendai virus. The
Sendai viral sequence is that of Richardson et al. (35); a similar sequence was determined by Gething et al. (34), except that position 8 is Ile and
position 13 is Pro. The underlined positions in the Sendai viral sequence are identical in simian virus 5 and Newcastle disease virus (35). The
double-underlined positions in the RS viral sequence are identical in Sendai virus.
acid sequence of the RS viral Fo protein for tripeptides re-
sembling the NH2 termini of the F1 polypeptides of the other
paramyxoviruses provided no evidence of an alternate, more
homologous candidate to be the NH2 terminus of the. RS vi-
ral F1 polypeptide. As has been noted previously (3; 34), the
NH2 termini of the F1 polypeptide of Sendai virus and the
HA2 polypeptides of influenza virus types A and B are simi-
lar in sequence for the first 12 or 13 amino acids, having
identity at 6 positions. This similarity in structure was
thought to reflect similarity in function. However, the corre-
sponding sequences of RS virus and human influenza virus
types A, B, and C (39) share only 1-4 amino acids out of 20
(not shown). The two common features of these RS viral,
Sendai viral, and influenza viral sequences are (i) overall hy-
drophobicity and (ii) the occurrence of glycine residues at
intervals in each sequence, which, as destabilizers of a-heli-
cal and P-sheet conformations (30), might contribute to simi-
lar secondary structures (40). Among RS virus and the other
paramyxoviruses, a third similarity is the sequence NH2-
Phe-X-Gly at the exact F1 subunit terminus. Othervise, the
general dissimilarity of the RS viral sequence suggqsts that
fusion activity depends upon general features of hydropho-
bicity and possibly secondary structure rather than upon a
common amino acid sequence.
In conclusion, this report describes the sequences and
structural features of the F mRNA and F protein ofRS virus.
The general structural features described here for the F pro-
tein were consistent with the available data for other para-
myxoviruses. However, specific nucleotide and amino acid
sequences that might be expected to have been conserved
among closely related viruses were dissimilar in RS virus in
comparison with Sendai virus. These observations are sug-
gestive of evolutionary distance 'within the paramyxovirus
family between RS v'irus and other paramyxoviruses exem-
plified by Sendai virus.
Note Added in Proof. Further work has identified the 5' termini of
the 1A, 1B, and 1C mrnNAs as 5' G-G-G-G, 5' N-G-G-G, and
5' G-G-G-G, respectively, with N representing an unidentified nu-
cleotide. Comparison ot the sequence of the phosphoprotein mRNA
with the sequences shdwn in Fig. 4 indicates that the 3' terminal
sequence that is cdhserved among nine RS viral mRNAs is
5' A-G-u-AU A-(N)1_4-p~,oly(A).
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